Toggle navigation
Home
Search
Services
Blog
Contact
About
Phosphoramidate Based Antisense Inhibitors Nf-Kb
Nerenberg, Michael I.
Lynx Therapeutics, Inc., Hayward, CA, United States
Search 10 grants from Michael Nerenberg
Search grants from Lynx Therapeutics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Impact of Neprilysin on Islet Function
Dayton Clinical Oncology Program
Role of Smad proteins in cell growth regulation
Risk Factors for Fatal Child Abuse and Neglect
Analysis of Physiological Signals
Recently added grants:
Macrophage small RNA export to HDL protects against inflammation and atherosclerosis
Modification of HDL and Macrophage Function in Atherosclerosis
Synergistic Effects of Anxiety and Alcohol Use among Latinos and its Sociocultural Mechanisms
Decision Making on Continuous Scales in Aging and Alzheimers Disease
Imaging Tauopathy in the Dominanatly Inherited Alzheimer Network (DIAN)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41CA071143-01
Application #
2009915
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (21))
Project Start
1996-09-15
Project End
1998-04-30
Budget Start
1996-09-15
Budget End
1998-04-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Lynx Therapeutics, Inc.
Department
Type
DUNS #
City
Hayward
State
CA
Country
United States
Zip Code
94545
Publications
Wang, L; Gryaznov, S; Nerenberg, M
(1999)
Inhibition of IL-6 in mice by anti-NF-kappaB oligodeoxyribonucleotide N3'-->oligodeoxyribonnucleotide N3' --> P5' phosphoramidates.
Inflammation 23:583-90
Comments
Be the first to comment on Michael Nerenberg's grant